SELECTBIO Conferences Regenerative Medicine & Cell Therapy Asia 2023

Submission Guidelines

Poster Submission Deadline: 15 September 2023

All abstracts will be reviewed by the Scientific Advisory Board and applicants will be notified of the result in due course.

Successful applicants will be provided with all necessary information.

Abstract Content:

  • Written in English
  • Written in the third person
  • Include title, name(s) and affiliation(s) of the authors
  • Between 100 - 200 words
  • Suitable for direct publication in the proceedings pack and on the website
  • Related to the subject of the conference

Agenda Topics

  • Cancer Immunotherapy: CAR-T, NK, Checkpoint Inhibitors
  • Cell & Gene Therapies: Technologies and Clinical Status
  • Clinical Trials and Commercialization of Cell Therapies
  • Extracellular Vesicles (EVs): Potential for Regenerative Medicine
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Stem Cells for Cellular Therapy


The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.

Choose your language